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Abstract: Members of the marine dinoflagellate genus Alexandrium are known to exude 
allelochemicals, unrelated to well-known neurotoxins (PSP-toxins, spirolides), with 
negative effects on other phytoplankton and marine grazers. Physico/chemical 
characterization of extracellular lytic compounds of A. tamarense, quantified by 
Rhodomonas salina bioassay, showed that the lytic activity, and hence presumably the 
compounds were stable over wide ranges of temperatures and pH and were refractory to 
bacterial degradation. Two distinct lytic fractions were collected by reversed-phase   
solid-phase extraction. The more hydrophilic fraction accounted for about 2% of the whole 
lytic activity of the A. tamarense culture supernatant, while the less hydrophilic one 
accounted for about 98% of activity. Although temporal stability of the compounds is high, 
substantial losses were evident during purification. Lytic activity was best removed from 
aqueous phase with chloroform-methanol (3:1). A “pseudo-loss” of lytic activity in 
undisturbed and low-concentrated samples and high activity of an emulsion between 
aqueous and n-hexane phase after liquid-liquid partition are strong evidence for the 
presence of amphipathic compounds. Lytic activity in the early fraction of gel permeation 
chromatography and lack of activity after 5 kD ultrafiltration indicate that the lytic agents 
form large aggregates or macromolecular complexes. 
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1. Introduction 
 
Phytoplankton in aquatic systems face various survival challenges, some of which result from 
grazer attack, pathogens and competition with other microalgae. The performance of particular species 
in these inter-specific interactions is assumed to play an important role in determining which species 
will survive and even to grow rapidly enough to form aggregations (i.e., “bloom”) at a given time and 
place. Some algal blooms cause adverse effects including oxygen depletion, reduced water quality, and 
toxicity, and they are therefore called Harmful Algal Blooms (HABs). Interestingly, many HAB 
species are regarded as rather poor exploitation competitors in terms of growth rate and/or resource 
uptake capabilities [1]. In compensation, the hypothesis evolved that a number of HAB species may 
gain dominance or at least maintain co-existence by production of bioactive compounds, particularly 
secondary metabolites that affect growth or elicit other physiological responses in other organisms. 
Such allelochemicals may be targeted to exclude competitors from exploiting limited resources 
(interference competition), as well as to avoid/reduce predation. In the marine environment, several 
HAB species from different groups, including cyanobacteria, dinoflagellates, prymnesiophytes and 
raphidophytes are known to produce such allelopathic chemicals with negative effects, such as 
inhibition of growth, photosynthesis pathway system II, grazing pressure, and even causing death of 
other protists [2–4]. In most cases, however, the chemical identity of the compounds remains   
unknown [5,6]. 
Marine dinoflagellates in the genus Alexandrium are among the most prominent HAB organisms, 
occurring worldwide, primarily in coastal ecosystems from polar latitudes through temperate waters 
and including even tropical regimes. Alexandrium species frequently form toxic blooms and are well 
known for their production of biologically active secondary metabolites [e.g., paralytic shellfish 
poisoning (PSP) toxins, spirolides]. For most of these compounds both the chemical structure and 
toxicity are well known, mainly because they are toxic to mammals and are therefore of concern to 
human health [7]. These compounds have been regarded as putative “defensive compounds” because 
of their high potency in mammalian systems, and they are also suspected to be allelopathic agents 
responsible for the deleterious effects on metazoan and protistan grazers and algal competitors [8–11]. 
Whereas the defensive role of the known phycotoxins may remain valid at least in some cases 
involving metazoan grazers [12], with respect to protistan targets, it is now quite clear that neither PSP 
toxins nor spirolides are involved in the observed negative effects [13,14]. Thus, it is evident that 
Alexandrium spp., in addition to the neurotoxic PSP toxins, produce still unknown compounds with 
lytic capacities. These unknown allelochemicals may be significant in explaining the formation and 
maintenance of Alexandrium blooms through direct destructive effects on competing algae or 
unicellular grazers [13,15–17]. 
The search for the chemical nature and structure of allelochemical substances that mediate effects 
among marine protists, based on classical bioassay-driven fractionation have often resulted in loss of 
activity or led to irreproducible or inconclusive results. The aim of this current study was to investigate 
the basic properties and the physico-chemical behavior of these poorly examined compounds, tracking 
activity with an ecologically realistic target bioassay organism. The lytic activity of cell free 
supernatant of A. tamarense stationary cultures was quantified via a microalgal (Rhodomonas salina) 
bioassay system to estimate stability, solubility, extractability, molecular size, and polarity of lytic Mar. Drugs 2009, 7 
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compounds. Although chemical structures of these allelochemicals have not yet been deduced via 
these experiments, results of liquid-liquid partition provide evidence for amphipathic compounds, 
while size-differentiation by ultrafiltration supports the existence of the lytic agents as large aggregates 
and likely as macromolecular complexes. Preliminary evidence indicates that they are stable over a 
longer period of time, but nonetheless show unusual unstable characteristics during any further 
purification, which often result in reduced or no activity. 
 
2. Results 
 
Temporal stability 
 
After storage of diluted (1:10) cell-free culture supernatant in 20 mL glass vials under normal 
culture conditions (15 °C), lytic activity rapidly declined, with an almost 50% reduction after 4 days 
and a complete disappearance after 7 days (Figure 1).  
 
Figure 1. Mortality of R. salina [%] exposed to supernatant stored for 1, 4, 7, and 14 days 
at 15 ºC. Results expressed as triplicate mean ± 1SD. 
0
20
40
60
80
100
120
147 1 4
storage time [d]
R
.
 
s
a
l
i
n
a
 
m
o
r
t
a
l
i
t
y
 
[
%
]
Undisturbed
Shaken
 
 
Lytic activity was however easily reestablished by shaking the containers vigorously before 
removal of stored supernatant. Even after 14 days the apparent loss of lytic activity could be 
reestablished by shaking. With a vigorous shaking before sub-sampling, a detailed quantitative 
experiment on stability under normal culture conditions was then performed. For the initial sample, the 
dilution curve (Figure 2A) yielded an EC50 value of 1.3% (1.2–1.4%; sample concentration in %). 
EC50 values determined after different storage time varied, but with an overall mean of 1.6% did not 
show any significant decrease in lytic activity over time, neither in flasks kept in the light nor in 
darkness (Figure 2B). Bacterial concentration in the stored supernatant, as determined for Day 7, was 
high (light: 1.63 ± 0.35 × 10
7 mL
-1: dark: 1.52 ± 0.19 × 10
7 mL
-1) and not significantly different 
between light and dark bottles (t-test, n = 2). Mar. Drugs 2009, 7 
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Figure 2. Stability of lytic activity of supernatant after storage under culture conditions. 
(A) Initial dilution curve of supernatant. Intact R. salina (% of control) is plotted against 
concentration of sample (%, v/v) in the bioassay (log scale). Error bars represent triplicate 
means ± 1SD. (B) time course of EC50 values of samples stored in light (hatched bars) or 
dark (grey bars). Bars represent duplicate mean ± 1SD. 
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Temperature stability  
 
As shown above, lytic compounds are stable at room temperature and also did not lose lytic activity 
upon freezing. After storage at -20 °C for three months, lytic activity was still high (Figure 3) with 
only minor losses compared to a sub-sample measured before freezing.  
 
Figure 3. Intact cells of R. salina (% of control) exposed to a dilution series of supernatant 
before (grey dots) and after 3 months storage at -20 °C (white dots). Symbols represent 
triplicate mean ± 1SD. Figure insert shows corresponding EC50 values (95% confidence 
interval). 
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Supernatant could also be lyophilized without losing activity; the EC50 value of lyophilized and re-
dissolved sample was 0.4% (0.4–0.5%), which was only a slight decrease compared to untreated 
original supernatant [EC50 = 0.3% (0.3–0.3%)]. With respect to heat stability, when exposed to higher 
temperature (95 °C) for 15 min the lytic activity of A. tamarense supernatant decreased significantly 
[EC50 = 46.3% (38.8–55.3%)], but only slightly decreased at 60 °C [EC50 = 1.5% (1.5–1.6%)] in 
comparison to room temperature [EC50 = 1.1% (1.0–1.3%)]. Lysis of Rhodomonas was still visible 
with samples heated to 95 °C, but 98% of the activity was lost. In undiluted samples, lytic activity was  
still present when samples were stored for 1 day at 95 °C (Rhodomonas mortality: 97 ± 0.1%); after 
two days at 95 °C, no lytic activity was detected (data not shown; cell numbers of sample not 
significantly different from control, t-test, n = 2). 
 
pH stability 
 
Lytic activity of a 1:10 diluted supernatant was detected in all samples stored for 3 days at various 
pH ranging from 2 to 12. Maximum lytic activity was observed at pH 8 and lytic activity decreased 
with higher and lower pH, but did not disappear completely (Figure 4). 
 
Figure 4. Mortality of R. salina cells (%) exposed to supernatant (1:10 diluted) after   
3-day storage at pH 2 to 12 at 15 ºC. Samples were re-adjusted to pH 8 before performing 
the bioassay. Results expressed as duplicate mean ± 1SD. sup. = supernatant (positive 
control). 
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Solubility  
 
Liquid-liquid partitioning between aqueous supernatant and n-hexane revealed formation of a stable 
emulsion between the aqueous and n-hexane phase, which did not disintegrate even after prolonged 
time. This emulsion layer was therefore also sampled for quantification of lytic activity. Highest lytic 
activity [EC50 = 6.7% (5.3–8.3%)] was indeed found in this layer, whereas no activity was detected in 
the n-hexane phase. Lytic activity in the aqueous phase was intermediate [EC50 = 16.8% (9.4–30.0%)] 
but reproducibility among replicates was rather poor. Generally, lytic activity recovered from liquid-
liquid partitioning was only about 10% of the lytic activity of the original supernatant   Mar. Drugs 2009, 7 
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[EC50 = 0.5% (0.5-0.5%)]. No lytic activity was detected in any fraction of negative controls from non-
lytic strain Alex5 culture supernatant (data not shown). 
When the supernatant was pre-acidified to pH 2, and then extracted with n-hexane, the mortality of 
Rhodomonas  in response to the n-hexane phase was still not different from the control (data not 
shown). However, the lytic activity in the remaining aqueous phase was also extremely low, and with 
poor reproducibility, the one-point (3.9 mL) mortality of Rhodomonas was 42.0 ± 41.9% (n = 3), at 
least 10-fold lower than with the original supernatant (at 1:10 dilution yielded mortality of   
100 ± 0% (n = 3). Both the n-hexane phase and aqueous phase from Alex5 showed no apparent 
difference from control (data not shown).  
When using extraction solvents with intermediate polarity, both dichloromethane-methanol and 
chloroform-methanol, did extract components with lytic activity from the aqueous phase. With 
dichloromethane-methanol mixtures, little but significant activity was still detected in the aqueous 
phase (Figure 5A). Lytic activity was completely removed from aqueous phase with chloroform-
methanol in a 3:1 mixture (Figure 5B). When compared to the original supernatant   
(EC50 = 0.2%) a slight loss of lytic activity was observed for all liquid-liquid partitioning experiments. 
The lack of detectable lytic activity in negative control samples (K-medium, data not shown) excluded 
any solvent effects. 
 
Figure 5. Intact cells of R. salina (% of control) exposed to dilution series of supernatant 
(black dots) or to organic phase (white symbols) and aqueous phase (grey symbols) of 
supernatant extracted with organic solvents with various composition and ratio.   
(A) dichloromethane: methanol; (B) chloroform: methanol. AP = aqueous phase;   
OP = organic phase. 
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Concentration of lytic compound(s) 
 
Attempts to concentrate lytic activity by taking up methanolic extracts in less volume than the 
original supernatant were partially successful. When compared to untreated supernatant, methanol 
extraction and re-suspension in the same volume yielded > 40% loss of activity (Figure 6). However, 
lytic activity increased almost linearly in samples re-suspended in a reduced volume, with lytic activity 
nearly reaching 300% of the untreated supernatant in the five-fold concentrated sample. Further 
concentration did not to apparently increase lytic activity per unit volume, and reproducibility of the 
activity of the highest concentrated samples was poor. 
 
Figure 6. Intact cells of R. salina (% of control) exposed to dilution series of supernatant 
(grey dots) or to chloroform-methanol [3:1 (v/v)] extracted supernatant at 4 concentrations. 
Results expressed as triplicate mean ± 1SD. 
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Ultrafiltration 
 
The mass range of the lytic compounds was estimated via ultrafiltration with 5 kDa and 500 kDa 
cut-off membranes. When small volumes of supernatant (e.g., 20 mL) were initially applied to the 
ultrafiltration unit with a cutoff 500 kDa membrane, no activity was detected in the filtrate (results not 
shown).  
However, when 100 mL supernatant were passed through a 500 kDa membrane, activity was found 
in the initial filtrate and increased in filtrates of subsequent runs (Figure 7A). Ultrafiltration through a 
5 kDa cut-off membrane showed no significant activity in any of the four filtrates, even though four x 
100 mL of supernatant were subsequently filtered (Figure 7B). Lytic activity in residues after 5 kDa 
ultrafiltration was considerably lower compared to untreated supernatant (Figure 8). A drastic decrease 
was observed between supernatant (EC50 = 0.8%) and the residue of the first run (EC50 = 6.1%), 
whereas subsequent ultrafiltration runs did not yield a further decrease of lytic activity (EC50 = 4.9%). 
 
 Mar. Drugs 2009, 7 
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Figure 7. Mortality of R. salina exposed to supernatant ultrafiltrate or to supernatant of the 
same batch (positive control). (A) 500 kDa cutoff filtrate; 100 mL 1 = first 100 mL filtrate 
of 100 mL supernatant; 100 mL 2 = second 100 mL filtrate of 100 mL supernatant.   
(B) 5 kDa cutoff filtrate; 100 mL 1 = first 100 mL filtrate of 120 mL supernatant;   
100 mL 2 = second 100 mL filtrate of 120 mL supernatant; 100 mL 3 = third 100 mL 
filtrate of 120 mL supernatant; 100 mL 4 = fourth 100 mL filtrate of 120 mL supernatant. 
Results expressed as duplicate mean ± 1SD. 
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Figure 8. Intact cells of R. salina (% of control) exposed to dilution series of supernatant 
(grey dots) or residues from 5 kDa ultrafiltration from the first and fourth run of filtration 
(see text). Results expressed as duplicate mean ± 1SD. 
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Gel permeation chromatography (GPC) 
 
When 5 mL of concentrated supernatant (extracted from 50 mL supernatant by chloroform-
methanol (3:1) and concentrated to 5 mL) were applied to a Superdex 30 gel permeation column for 
size determination, lytic activity was primarily found in Fraction 3 and to a lesser extent in Fraction 4 
(Figure 9). These were the first fractions collected after the void volume. Quantitative evaluation of the 
GPC method revealed very poor recovery of lytic activity. An equivalent to 150 mL supernatant 
(extracted and concentrated to 15 mL) was injected in 3 subsequent runs and pooling of the Mar. Drugs 2009, 7 
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corresponding fractions allowed for a detailed quantification of lytic activity by preparing dilution 
curves. Corresponding EC50 values [Supernatant = 2.2% (2.0–2.5%); GPC fraction = 7.3%   
(6.4–8.3%)] indicate that only 1% of the activity was recovered after GPC. 
 
Figure 9. Mortality of R. salina (%) exposed to fractions collected after gel permeation 
chromatography. The first two fractions correspond to the column void volume. 
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Clean-up by solid phase extraction (SPE) 
 
Initial clean-up experiments on the cell-free culture supernatant by reversed phase SPE C-18 
cartridge yielded no apparent mortality of Rhodomonas after treatment with 100% methanol SPE 
eluent of sample loading volumes up to 100 mL.  
 
Figure 10. Mortality of R. salina (%) exposed to different eluate fractions obtained after 
reversed phase solid phase extraction (SPE) of 200 mL supernatant (Alex2, grey bar) or 
200 mL K-medium (negative control, KM (K-medium), black bar): 195–200 = last 5 mL 
sample load eluate; H2O = water wash; 20–100% = percentage of aqueous methanol; 
CHCl3-MeOH = 1:1 (v/v) mixture of chloroform/methanol; Sup = untreated supernatant 
(positive control). Results expressed as triplicate mean ± 1SD. 
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Yet 100% mortality of Rhodomonas was observed when at least 200 mL of supernatant were loaded 
onto the SPE cartridge. Sequential elution of the SPE cartridge with eluents of increasing (10% 
increments) methanol content revealed two distinct fractions containing lytic activity. An initial 
hydrophilic fraction contained lytic activity spread over the five mL (195 to 200 mL) of the sample 
load eluate, the water wash and the 20% methanol fraction. Fractions containing 30 to 50% methanol 
did not show any lytic activity. A second more lipophilic fraction with lytic activity was detected in the 
eluates with 60% to 80% methanol (Figure 10).  
 
Figure 11. R. salina exposed to consecutive eluate fractions (as indicated below the bars) 
of reversed phase solid phase extraction (SPE) of 200 mL supernatant or exposed to 
untreated supernatant (positive control). (A). R. salina mortality from one-point bioassay. 
(B). EC50 and 95% confidence interval. Results expressed as duplicate mean ± 1SD. 
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Lytic activity appeared in the sample load eluate only after 40 mL supernatant was applied   
(Figure 11). Interestingly, the EC50 of the sample load eluate, separately measured for consecutively 
collected fractions (20 mL each), did not change (Figure 11). With an average EC50 of 20.3%, lytic 
activity in the sample load eluate accounted for about 2% of the total lytic potency of the supernatant. 
The 80% methanol Fraction 2 was much more lytic (EC50 = 1.0%) than the water-20% methanol 
Fraction (EC50: 29.9%) (Figure 12). When taking the different volumes into account, the lytic activity 
of Fraction 2 was about 2.5% of the total lytic activity of 200 mL supernatant (EC50 = 0.5%) applied to 
the SPE cartridge. Total loss of activity after SPE was calculated as 96%. Re-dissolving Fraction 2 in 
the sample load eluate did not significantly increase lytic activity, indicating that there is no major 
synergistic effect of lytic compounds of the separate fractions. Eluates from SPE of supernatant of a 
culture of the non-lytic clone Alex5 (negative control) yielded no lytic activity (not shown), therefore 
sample treatment artifacts causing cell lysis of Rhodomonas can be excluded.  
 
Figure 12. Intact cells of R. salina (% of control) exposed to different eluate fractions of 
200 mL supernatant obtained with reversed phase solid phase extraction (SPE) or to 
dilutions of untreated supernatant (black dots, positive control): 80% MeOH = 5mL aliquot 
of 80% methanol fraction, evaporated and dissolved in 5 mL K-medium; 80% MeOH   
mix = 5 mL aliquot of 80% methanol fraction evaporated and dissolved in 5mL of last  
20 mL sample load eluate; H2O-20% MeOH combined = 10 mL water and 10 mL 20% 
methanol fraction evaporated and dissolved in 20 mL K-medium. Results expressed as 
duplicate mean ± 1SD. 
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Effects of SPE fraction storage conditions on lytic activity 
 
Storage of lytic active eluates from reversed phase SPE in seawater-base culture medium yielded 
markedly different effects, depending upon the specific storage conditions. Re-suspension of dried 
SPE fraction in seawater based K-medium resulted in higher lytic activity (lowest EC50 value, Table 1) 
than for fractions kept for two days as dry residue or in 80% aqueous methanol. In contrast, storage of 
SPE fractions in deionized water drastically decreased lytic activity in the subsequent bioassay to such Mar. Drugs 2009, 7 
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an extent that EC50 was almost one tenth of the lytic activity of fractions stored in K-medium   
(Figure 13A, and Table 1). However, after additional 2 days stored in seawater culture medium, lytic 
activity of this sample was largely restored (Figure 13B and Table 1). A comparable but smaller 
increase in lytic activity upon additional storage in seawater (significant for the treatment “dryness”) 
was observed for the two other samples.  
 
Table 1. EC50 (sample %) and 95% confidence intervals for SPE lytic fraction dissolved 
and stored in four different ways. 
Treatment EC50 (%) pre-treatment  EC50 (%) after treatment 
80% methanol  3.4 (2.8–4.2)  2.8 (2.7–2.9) 
Water  22.2 (19.4–25.4)  5.0 (4.3–5.8) 
K-medium  2.1 (1.9–2.3)  2.3 (1.9–2.8) 
Dryness  4.1 (3.5–4.7)  2.6 (2.6–2.7) 
 
Figure 13. Intact cells of R. salina (% of control) exposed to four 80% methanol SPE 
fractions of supernatant, each stored at different conditions (for explanation see text): 80% 
MeOH = unchanged; H2O = solvent evaporated and re-dissolved in deionized water;   
K-Medium = solvent evaporated and re-dissolved in K-medium; Dryness = solvent 
evaporated. (A) after 2 days storage. (B) after additional 2 days storage in K-medium. 
Results expressed as duplicate mean ± 1SD. 
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Reversed phase high performance liquid chromatography (HPLC) 
 
Reversed phase chromatography of SPE pre-cleaned supernatant (80% methanol eluate) on a 
lipophilic C8 phase yielded an active fraction between 18 and 19 min. None of the other fractions 
collected in one minute increments showed any lytic activity in the Rhodomonas bioassay. The 18 to 
19 min window of the chromatogram also revealed a peak in the diode array detector (DAD). The UV 
spectrum of this peak had an absorption maximum at 236 nm. However, the same UV spectra were 
also observed in neighboring peaks, which showed no lytic activity of the lytic Alex2 supernatant, nor 
of the same chromatographic region of the non-lytic Alex5 supernatant.  
 
Dry mass equivalent 
 
The EC50 was reached with 1.9 mg (1.7–2.1 mg) of dried supernatant. After clean-up by reversed 
phase SPE, the EC50 was equivalent to 78 µg (60–101 µg) of the 80% methanol fraction. The same 
activity was achieved with 31 µg (28–34 µg) of the lytic HPLC fraction (18–19 min). These results 
indicated that 96% of interfering substances in the supernatant were removed by the SPE clean-up. Salt 
removal from the supernatant mainly contributes to this reduction of dry mass equivalent. Further 
separation by C8 HPLC additionally excluded approximately another 60% of dry mass not related to 
lytic activity. 
 
3. Discussion 
 
Species of the genus Alexandrium are well known for their production of biologically active 
secondary metabolites. For some of these compounds, particularly the neurotoxins associated with 
paralytic shellfish poisoning (PSP) (saxitoxin and derivatives) and the macrocyclic imine toxins 
spirolides, both the chemical structures and toxicity are well known, mainly because these compounds 
are toxic to mammals. In contrast, other compounds are well described in terms of their bioactivity 
toward ecologically meaningful targets (e.g., lytic activity against accompanying protists), but detailed 
structural information is completely lacking. Whereas the known phycotoxins (PSP, spirolides) are 
mainly stored inside the cells, the toxicity of Alexandrium to other protists is caused by lytic 
compounds excreted to the medium, facilitating direct contact to competing and interacting protistan 
species. Consequently, in our attempts to characterize allelochemicals of A. tamarense with lytic 
effects on marine protists, we exclusively focused on extracellular compounds to be found in the 
culture medium. This approach is justified per se by the term “allelopathy”, coined by Molisch [18] as 
defining effects through the production of chemicals that are released into the environment to affect 
other species, and by the notion that compounds enclosed inside cells cannot directly affect co-existing 
planktonic species in the absence of cell lysis (death). The high ecological relevance of investigating 
potential allelochemicals in the extracellular matrix, however, is saddled with all the disadvantages 
associated with extracting diluted metabolites from aqueous media such as seawater. In order to gain a 
maximum concentration of lytic compounds in the cell-free fraction, we sampled dense, stationary 
cultures, which have been shown to contain highest lytic activity (unpublished results). Centrifugation 
to separate cells and cell-free supernatant was preferred because filtration was shown to drastically Mar. Drugs 2009, 7 
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reduce lytic activity [4], probably both due to filter pore-size restriction and adsorption to filter 
material.  
The successful search for allelochemicals is also highly dependent upon the appropriate choice of 
bioassay to follow biological activity. Rather than the commonly used brine shrimp or mammalian cell 
lines, we selected the small cryptophyte Rhodomonas salina, which co-occurs with Alexandrium in 
coastal marine systems and thus is an ecologically relevant bioassay organism. Furthermore, previous 
experiments [14,39] have shown that R. salina is rapidly susceptible to easily quantifiable 
allelochemical interactions with other protists and can therefore serve to follow bioactivity for 
physico-chemical characterization. 
Previous attempts to purify and isolate these allelochemical compounds by classical bioassay-
driven fractionation often resulted in loss of activity and erratic and irreproducible results. For this 
reason we decided to carefully characterize the properties and behavior of these compounds before 
starting their isolation. As a prerequisite for effective bioassay-guided fractionation it is necessary to 
obtain basic information on physico-chemical properties of the target compounds. The stability of the 
compounds, or more precisely the stability of the biological effect quantified with the bioassay is 
important. For example, toxic compounds of the haptophyte Prymnesium parvum have been shown to 
rapidly degrade with time, especially under the influence of light [19,20]. Lability of compounds is 
likely to have also exacerbated identification of potential toxins produced by the putatively toxic 
dinoflagellate Pfiesteria piscicida [21]. In contrast, the high stability of extracellular lytic compounds 
from  A. tamarense under moderate conditions (e.g., normal room temperature and ambient light) 
significantly relaxes requirements for further treatment for purification and identification. Heat 
stability of lytic activity was also high; almost no loss of activity after heating at 60 °C indicates that 
enzymatic activity is not involved in lysing target cells. Moreover, temporal stability in the presence of 
bacteria (Figure 2B, Day 7) showed that lytic compounds are refractory to bacterial degradation (at 
least of the bacterial consortium typically present in the culture medium). From an ecological point of 
view, this stability is important because it increases the probability that biologically active threshold 
concentrations of these compounds in the water are reached and maintained for the benefit of the 
producing organisms. 
Perhaps surprisingly given the complexity of the probable macromolecular structures lyophilization 
of supernatant hardly altered lytic activity after resuspension in culture medium. Yet the lytic effect of 
cell-free supernatant appeared to rapidly decrease (Figure 1) when samples were collected with 
minimal physical disturbance, whereas after vigorous shaking lytic activity was fully recovered. This 
finding may accord with an observed “loss” of hemolytic activity of putative toxins of the haptophyte 
Prymnesium parvum, depending on the surface/volume ratio of different storage containers [22], which 
was explained by a movement of monomers of these amphipathic molecules to the surface. 
Amphipathic compounds, such as detergents and surfactants, are generally large molecules 
composed of an ionic or non-ionic polar head and a hydrophobic part, which promote the formation of 
aggregates (micelles, bilayers, monolayers, hexagonal or cubic phase) in aqueous media. Most 
important, physico-chemical behavior and properties of amphipathic compounds are strongly 
modulated by self-association or by their binding to other lipophilic aggregates. Monomers and 
aggregates can be interconverted as a function of pH, temperature, ionic strength, and concentration of Mar. Drugs 2009, 7 
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the compounds (for a review, [23]), the latter being described by the critical micelle concentration 
below which compounds mostly occur as monomers. 
Bioactive compounds from other toxic marine flagellates, including species of Prymnesium, 
Amphidinium and Karlodinium, have been shown to behave like amphipathic molecules [22,24,25], 
which also seems to be the case for the lytic compounds of Alexandrium. In addition to the observed 
loss of activity after filtration [4] and the “pseudo-loss” of undisturbed and low-concentrated samples, 
the observed high lytic activity of the emulsion between aqueous and n-hexane phase after liquid-
liquid partition is a strong indication for amphipathic compounds. Likewise, attempts to estimate 
molecular size are largely hampered for micelle-forming compounds. The loss of activity after 
filtration using small pore-sized filters, appearance of lytic activity in the first fraction of gel 
permeation chromatography and lack of activity after 5 kD ultrafiltration are indications that the lytic 
agents are unusually large complexes because of micelle formation.  
Fatty acids have been reported to be associated with hemolytic, antibacterial or anti-algal effects in 
several dinoflagellate species [26–29]. However, n-hexane extraction of acidified supernatant did not 
show any lytic activity in the bioassay, from which we conclude that fatty acids alone are not 
responsible for Alexandrium extracellular lytic activity. 
The results further show that, although temporal stability of the compounds is high, substantial 
losses seem to be unavoidable during purification. This may be generally explained by a “stickiness” 
of the compounds to various surfaces, as has been described for filter material [4] and differentially for 
plastic containers compared to glass (unpublished data). A high adsorption of bioactive compounds to 
various materials has also been observed for karlotoxins [30] and might be explained by high charge of 
the micelle surface, yet another indication of the amphipathic nature of these compounds.  
It is also interesting to consider how storage conditions affected lytic activity. Pretreatment of the 
partly purified lytic fraction in seawater – compared to ion-free water or different solvents - increased 
the activity (Figure 13). A similar phenomenon is described for Prymnesium toxins. When 
Prymnesium toxin B was diluted in methanol, ethanol or chloroform-methanol (2:1, v/v), or distilled 
water, the resultant hemolytic activity was approximately 10-fold decreased when compared to the 
sample dissolved in 0.85% NaCl [22]. Ions thus are able to modify lytic activity of amphipathic 
compounds, probably by affecting the solubility of relatively non-polar compounds in water or their 
partitioning between water and organic solvents [31]. 
Apparently, two distinct lytic fractions with different polarity (high polarity: eluted with 20% 
methanol; low polarity: eluted with 80% methanol) were separated via reverse SPE (Figure 10). EC50 
values of both fractions indicate that lytic activity of the less polar fraction was about 15 fold higher. 
The fact that some lytic activity already appears very early in the sample load eluate (Figure 11) is a 
strong indication that this fraction is very hydrophilic and hardly retained on the lipophilic material of 
the C-18 SPE cartridge. This hypothesis is supported by the observation that the amount of lytic 
activity in the waste did not change after an initial increase (no mortality in the first 40 mL, and then 
100% mortality thereafter) and accounts for only a minor part (ca. 2%) of total activity of the 
supernatant. In contrast the less polar fraction could only be detected after loading more than 100 mL 
sample to the C-18 SPE cartridge suggesting a very strong absorption of this fraction to the cartridge 
material.  Mar. Drugs 2009, 7 
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Nevertheless, more than 95% of total activity of the supernatant applied to SPE could not be eluted 
from the column. It is unlikely that this loss was caused by nullifying synergisms of two different 
compounds now separated into two different fractions, as simple mixing of the two fractions did not 
significantly increase the lytic activity. A strong adsorption of the non-polar fraction to C-18 material, 
as has been found for all kind of surfaces, might be responsible for the large loss. 
The fact that lytic activity elutes in a discrete retention window between 18 and 19 minutes from a 
reversed C8 phase but does not show any specific absorption of UV radiation, may be explained by 
two alternative hypotheses: 1) lytic compounds are active at very low concentrations and coelute with 
compounds unrelated to lytic activity on this chromatographic system, or 2) lytic compounds belong to 
a suite of chemically similar (but non-lytic) compounds and only small modifications, which do not 
result in altered UV absorption, are responsible for lytic activity. Both hypotheses will have to be 
tested in future work. 
A still unresolved problem is the loss of activity after purification and separation of supernatant. 
Similar effects have been described for karlotoxins produced by Karlodinium spp. and for postulated 
exotoxins produced by Pfiesteria piscicida. Whereas karlotoxins have a high affinity to organic 
polymers, to such an extent that they can be extracted from aqueous media by filtration over polymer 
filters and eluted with methanol [30], the proposed Pfiesteria toxins consist of a metal complex and 
toxicity seems to be caused by production of free radicals and redox reactions [21]. Both 
characteristics, even though similar to karlotoxins and the bioactive components of Pfiesteria, can be 
excluded for lytic compounds from Alexandrium. The loss of activity after contact with organic 
polymeric material like SPE cartridges or filters is irreversible (in contrast to karlotoxin). On the other 
hand there is some parallel to the bioactive components of Pfiesteria because of the evidence that 
metals may play a role in Alexandrium lytic activity. This is supported by the fact that lytic fractions 
incubated in seawater-base culture medium show higher activity than fractions incubated in deionized 
water prior to the bioassay. Unlike for Pfiesteria, Alexandrium lytic activity is very stable and does not 
degrade easily, indicating that the bioactive agents of Pfiesteria and Alexandrium and their physico-
chemical properties are completely different.  
There are three other recent studies dealing with exotoxins of the genus Alexandrium. A heat-labile 
exotoxin which showed potent toxic effect on brine shrimp (Artemia salina) has been reported from A. 
minutum [32], and a hemolytic exotoxin of A. taylori has been described as proteinaceous, with a 
molecular weight of more than 10 kDa [33]. A novel high molecular weight (about 1,000 kDa) 
exotoxin (both hemolytic and cytotoxic) was reported from A. tamarense as most likely a 
polysaccharide-based compound [34]. The molecular weight estimated by Yamasaki et al. [34], 
however, could not be confirmed by our study, as lytic activity could be detected in the 500 KDa  
cut-off membrane filtrate. This might be due to the difficulties to correctly estimate molecular size of 
amphipathic compounds, or to the presence of different compounds in different species and/or strains 
of Alexandrium. Both Emura et al. [33] and Yamasaki et al. [34] used hemolytic and cytotoxicity 
assays in the search for novel ichthyotoxic compounds produced by blooms of Alexandrium species 
and affecting fish stocks in aquaculture. These studies did not specifically address or test for bioactive 
compounds associated with allelochemical interactions among protists. It is therefore not unlikely that 
the compounds represented by these previous studies have different properties and are unrelated to the 
lytic compounds we tested for in our Rhodomonas bioassay. Mar. Drugs 2009, 7 
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4. Experimental Section 
 
Cell culture 
 
One clonal isolate of Alexandrium tamarense (Alex2) was selected as the source of lytic 
compounds from a larger collection of >60 clones of the North American ribotype (Group 1, [35]) of 
this species isolated simultaneously in May, 2004 from the Scottish east coast of the North Sea   
(56° 05’ 47’’ N and 1° 42’ 35’’ W). The clones were isolated by micro-capillary pipette from a single 
vertical net haul (20 μm mesh) from 20 m depth [36] and maintained as unialgal stock cultures under 
standardized growth conditions. Dinoflagellate cultures were grown in K-medium [36,37], 
supplemented with selenite [38], prepared from sterile-filtered (VacuCap 0.2 μm Pall Life Sciences) 
natural North Sea seawater (salinity 32 psu) in 1,000 mL Erlenmeyer flasks. Cultures were maintained 
under controlled conditions at 15 ºC under cool-white fluorescent light at a photon flux density (PFD) 
of 100 µmol photons m
-2 s
-1 on a 16 h light: 8 h dark photocycle. Alex2 was selected based on its high 
lytic activity as comparatively quantified in previous experiments [36,39]. In some experiments, 
another isolate of this collection (Alex5), which does not produce lytic compounds in measurable 
amounts [39], was used as a negative control.  
 
Sample harvest and preparation  
 
Different techniques for maximum yield of extracellular lytic activity from A. tamarense cultures, 
including the optimal harvest time for extracellular lytic compounds, were previously compared 
(unpublished data). Based on these results, samples were prepared by separating cells from the culture 
medium by centrifugation (50 mL Sarstedt tubes, Eppendorf centrifuge 5810R, 3,220 × g, 15 ºC for  
10 min) of dense stationary phase cultures (ca. 20 x 10
3 cells mL
-1). Supernatant of several tubes was 
combined in glass vessels and either used directly or stored in the fridge (4 ºC for weeks).  
 
Chemical reagents 
 
Water was deionized and purified (Milli-Q, Millipore GmbH, Eschborn, Germany) to 18 MV cm
-1 
quality or better. Methanol (LiChrosolve for HPLC, and p.a. for all other experiment), chloroform 
(p.a.), dichloromethane (p.a.), hydrochloric acid (HCl, 32%, p.a.) and n-hexane (p.a.) were purchased 
from Merck (Darmstadt, Germany), and sodium hydroxide (NaOH, p.a.) were from Sigma (Aldrich, 
Germany). 
 
Bioassay system 
 
A microalgal bioassay system was used to quantify lytic activity based on the response of the 
photosynthetic cryptophyte Rhodomonas salina (Kalmar culture collection strain KAC 30, hereafter 
named “Rhodomonas”) as the target species. Rhodomonas was cultured under the same conditions as 
described for Alex2. In this bioassay, intact Rhodomonas cells were microscopically counted after 
short-term treatment with one or several dilutions of a sample and compared to cell numbers of a Mar. Drugs 2009, 7 
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control (treated with culture medium). The bioassay was set up in a total volume of 4 mL in 6 mL 
glass vials. Each sample was spiked with 0.1 mL of a Rhodomonas culture which was adjusted (based 
on microscope cell counts) to 4 × 10
5 cells mL
-1 to a final start concentration of 1 × 10
4 mL
-1 of the 
target cells in the bioassay. Samples were then incubated for 3 h in the dark at 15 °C. Subsequently, 
samples were fixed with 2% Lugol’s iodine solution and concentration of intact target cells was 
determined. All counts were performed with an inverted microscope (Zeiss Axiovert 40C, Göttingen, 
Germany) in 2 mL counting chambers. The volume set up for cell counts was 0.5 mL. A sub-area of 
the chamber corresponding to at least 600 Rhodomonas cells in the control was counted. In order to 
quantify lytic effects, only intact cells of the target species were scored. 
The bioassay was performed in two different ways. For the “one-point” approach to even detect a 
minor decline of lytic activity, one concentration of sample was applied and percent mortality (by 
comparing cell number to a control) were calculated as a measure of lytic activity of the sample, and in 
these experiments, the supernatant was properly diluted before the experiment to have a start activity 
of the compounds close to 100% target mortality. For detailed quantification, a dose response curve 
was determined, which allows for a calculation of EC50 concentration, i.e., the concentration of sample 
(as %, v/v) affecting 50% of the targets. As performing dose-response curves is rather time consuming, 
simple one-point measurements of target mortality was used in some of the following experiments.  
In one-point bioassays, mortality of Rhodomonas was calculated as:  
mortality = [1-(Rhofinal/Rhocontrol)]*100%, 
where Rhofinal is the experimental final Rhodomonas cell concentration, and Rhocontrol the final target 
cell concentration in controls. 
When performing dilution series experiments, the percentage of intact Rhodomonas followed a 
sigmoidal decreasing pattern when plotted against logarithmic-scaled sample concentration (as %, 
v/v)). Estimates of EC50, i.e., the volume of Alex2 supernatant yielding a 50% decline in target cell 
concentration, were determined by fitting the data points to the following equation using the non-linear 
fit procedure of Statistica1 (Statsoft, Hamburg, Germany) for Windows: 
Nfinal = Ncontrol/[1 + (X/EC50)
h] 
where Nfinal is the experimental final target percent intact cells (0–100%), Ncontrol the final target cell 
percentage in controls (100%), X the logarithmic-transformed percentage of volume of Alex2 
supernatant in the 4 mL test system, and EC50 and h are fit-parameters. Results are expressed as EC50 
(sample %) including 95% confidence intervals. 
For one-point measurements, t-test statistics with a significance level of 0.05 were used to identify 
significant differences between number of intact cells in samples and control, and also to compare 
replicate EC50 values. When single dilution curves were available, comparison of EC50 values was 
based on their 95% confidence intervals. 
 
Temporal stability 
 
Stability of lytic activity under normal culture incubation conditions was tested by filling 24 glass 
vials (Wheaton, 20 mL) each with 15 mL of 1:10 diluted (with K-medium) supernatant and following 
the decline in activity over time with a one-point bioassay. Incubated samples were stored in a culture Mar. Drugs 2009, 7 
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room at 15 ºC for 1, 4, 7 and 14 days, respectively. After each respective incubation period, six vials 
were removed; 3.9 mL sub-samples were taken without perturbation from three vials, whereas the 
other subset of three vials was shaken vigorously before sub-sampling. A Rhodomonas bioassay of 
these sub-samples was performed as described above. 
A fully quantitative estimation of stability under normal culture conditions was then performed as 
follows: 500 mL of supernatant was prepared and apportioned into 5 × 100 mL in 100 mL Duran glass 
flasks. From one flask, lytic activity was quantified from an 11 points dilution curve (each dilution in 
triplicate). The other flasks (in duplicates) were stored under normal dinoflagellate culture conditions 
(as described herein). One of the two sets of flasks was kept dark by wrapping with aluminum foil. 
After 1, 2, 4, 7, 12, 20 or 49 days, sub-samples of each flask were taken after vigorously shaking the 
flasks to perform a bioassay and the activity was determined from an 11-point dilution curve (each 
dilution in duplicate). For the final sampling (after 49 days), samples from flasks held in the light had 
to be omitted because a low but substantial number of cells was present, which had obviously 
originated from a few cells still present in the culture supernatant. After 7 days, 1 mL sub-samples 
from each flask were fixed with formalin (2% final concentration) for determining bacterial abundance 
according to a standard technique with acridine orange staining [40]. Stained bacteria were counted 
under an epifluorescence microscope (Zeiss Axiovert 2 Plus, Göttingen, Germany) with a   
100× magnification oil immersion objective. At least 400 cells per filter (except for blank filters) were 
counted. 
 
Temperature stability  
 
Effects of freezing were tested by a quantitative comparison of lytic activity of supernatant before 
and after prolonged (3 month) storage at -20 °C in the dark. A total of 200 mL supernatant was 
prepared and a standard bioassay to quantify lytic activity was performed (in triplicate) with a series of 
9 dilutions. Subsequently, an aliquot of 50 mL of the remaining supernatant was stored in the freezer at 
-20 °C in a glass bottle. After 3 months storage, the sample was thawed at room temperature and lytic 
activity was quantified from a 9-point dilution curve (in triplicate). 
Frozen supernatant (90 mL at -20 °C) was lyophilized by a Freeze Dryer Beta I (Martin Christ, 
Osterode am Harz, Germany) at -20 °C and ca. 0.004 mbar vacuum. After three days, the lyophilized 
sample was re-dissolved in 90 mL water, and lytic activity was quantified by an 8-point dilution series 
bioassay and compared to untreated supernatant, which was stored at 4 °C during lyophilization.  
Short-term heat stability was tested by incubating 20 mL supernatant in 20 mL glass vials in 
duplicate at room temperature (ca. 20 ºC) as control, and at 60 and 95 ºC, each in a water bath for  
15 min, respectively. The heated samples were rapidly cooled with ice to room temperature. From each 
sample, a Rhodomonas bioassay was performed as described above for the 9-point dilutions, with each 
dilution set up in triplicate. Based on the results of the first experiment, a second experiment was 
performed to test the long-term heat stability at 95 °C. Fifteen mL supernatant of another batch was 
incubated in duplicate in 20 mL glass vials in an oven at 95 °C for 1 and 2 days, respectively. After 
cooling the sample to room temperature, lytic activity was estimated with a one-point measurement of 
undiluted sample as described above. 
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pH stability 
 
The effect of storage at different pH on extracellular lytic compounds was tested as follows. Fifteen 
mL of 1:10 diluted supernatant in duplicate were stored in 20 mL glass vials at pH ranging from 2 to 
12. The pH was adjusted with NaOH (4 M and 0.1 M) and HCl (32% and 3.2%). Samples were stored 
for 3 days in the dark at 15 °C, and then adjusted with NaOH and HCl to pH 8. The increase in volume 
due to this adjustment was always below 1 mL. The Rhodomonas bioassay was carried out by applying 
2 mL sub-samples within the 4 mL bioassay system. 
 
Solubility 
 
Partitioning of lytic activity after solvent extraction was analyzed as a first step towards a chemical 
characterization. The prime task was to exclude the possible negative effect of n-hexane. 10 mL 
supernatant from both Alex2 and Alex5 cultures harvested in stationary phase   
(ca. 20 × 10
3 cells mL
-1) was extracted twice with 5 mL n-hexane (in triplicate); aqueous and n-hexane 
phases were separated by centrifugation (Eppendorf, 3220 × g, 5 min, 15 °C), and then evaporated by 
rotary evaporation at 40 ºC (Rotavapor, Büchi, Flawil, Switzerland) to dryness. The aqueous phase 
residues were redissolved in 10 mL water, whereas n-hexane phase residues were brought up in 10 mL 
K-medium. A one-point (3.9 mL) bioassay of each sample was performed. Accordingly, 5 mL 
supernatant in a 50 mL plastic Sarstedt tube was mixed with the same volume of n-hexane in triplicate, 
then the samples were centrifuged (3,220 × g, 5 min, 15 °C). Four mL of the n-hexane phase (top) and 
of the aqueous phase (bottom) were removed, and the 2 mL emulsion between the layers was also 
separately removed. All three phases were dried by rotary evaporation and n-hexane extracts and 
aqueous residues were dissolved in 4 mL K-medium or water, and the emulsion was taken up in 1 mL 
water and 4 mL K-medium, respectively. Bioassays were performed with a 6-point dilution series after 
sample storage at 4 °C for 2 days. 
Fifteen mL Alex2 as well as Alex5 supernatant in triplicates were acidified with 1 and 0.1 N HCl to  
pH 2.0. Then the samples were extracted three times with 5 mL n-hexane. The n-hexane phase was 
removed without interrupting the inter-phase, and then dried by rotary evaporation, and finally 
dissolved in 15 mL K-medium. The remaining aqueous phase was dried by rotary evaporation, and 
dissolved in 15 mL water, and finally adjusted to pH 8.0 with 1 and 0.1 N NaOH. One-point bioassays 
(3.9 mL) were performed with samples from both n-hexane and aqueous phases, with original Alex2 
supernatant as positive control. 
Chloroform, dichloromethane, methanol and mixtures of these solvents, which are less 
hydrophobic, were tested in different ratios (chloroform or dichloromethane: methanol = 3:1; 2:1;  
1:1 (v/v)). Twenty mL supernatant were mixed with 5 mL of each solvent combination, and 
subsequently centrifuged (3,220 × g, 5 min, 15 °C). Organic phases were carefully removed from the 
bottom with a pipette. The aqueous phase was extracted twice more with 5 mL each of the respective 
organic solvent, and then dried by rotary evaporation and dissolved in 20 mL water. The organic 
phases were combined and dried by rotary evaporation and finally dissolved in 20 mL K-medium. 
Lytic activity of both, organic and aqueous phases was measured by Rhodomonas bioassay with a  
10-point dilution series. Similarly, to exclude the negative effect of the organic solvents, the same Mar. Drugs 2009, 7 
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procedure was performed with the culture medium as negative control, and a one-point (3.9 mL) 
bioassay was performed. 
 
Concentration of lytic compound(s) 
 
To concentrate lytic activity for further analysis, 30 mL supernatant were extracted three times with 
5 mL chloroform/methanol (3:1 (v/v)) in triplicate. After evaporation to dryness, the residue of the 
organic phase was taken up in 3, 6, 15, 30 mL K-medium, respectively, to obtain a calculated 10, 5, 2, 
and 1-fold concentrated supernatant. Lytic activity was quantified with a 7-point dilution series.  
 
Ultrafiltration 
 
Ultrafiltration was performed with an ULTRAN
®-MiniFlex cross flow system (Schleicher & 
Schuell MicroScience, Dassel, Germany) with a filter area of 24 cm
2 per cassette, operated at a 
pressure between 1.0 to 1.8 bar. Ultrafiltration membranes PES 500 (cut-off 500 kD) and PES 5  
(cut-off 5 kDa) (Schleicher & Schuell MicroScience, Dassel, Germany) were used. For the 500 kDa 
membrane, 200 mL supernatant were applied until the retentate reservoir was empty. The filtrate was 
collected in two separate aliquots of 100 mL. Lytic activity of these two filtrate fractions was tested by 
taking 3.9 mL sub-samples (in duplicate) for a one-point Rhodomonas bioassay. With the 5 kDa   
cut-off membrane, 120 mL Alex2 supernatant were applied to the system, and 100 mL filtrate was 
collected. The residue of 20 mL was subsequently made up with 100 mL K-medium. This procedure 
was repeated three times. Sub-samples of 3.9 mL each were taken to estimate lytic activity in all four 
filtrates. A sub-sample of the first and fourth residue, as well as the supernatant batch applied to the 
PES 5 system, was tested with the Rhodomonas bioassay in a 9-point dilution series. 
 
Gel permeation chromatography (GPC) 
 
Fifty mL of supernatant were extracted with chloroform/methanol [3:1 (v/v)] as described above, 
and the residue of the rotary-evaporated organic phase was dissolved in 5 mL water. The concentrated 
sample was applied to a Superdex 30 GPC column (Hiload 16/60, 13,000 plates), with 40% methanol 
as eluent. Each run was performed for 120 min at a flow of 1.15 mL per min. For each run,   
12 fractions were collected (10 min for each tube), and rotary-evaporated to dryness. The residues 
were dissolved in 5 mL K-medium and incubated for two days. A one-point (3.9 mL) bioassay was 
performed as described above to determine lytic activity in each fraction, together with supernatant of 
the same batch as positive control. Subsequently, 150 mL supernatant was concentrated the same way 
to 15 mL, and was applied to the GPC column by injection in three subsequent portions. 
Corresponding fractions from all three runs were pooled and rotary-evaporated to dryness, and finally 
the lytic activity as well as supernatant of the same batch was tested via bioassay with a   
7-point dilution series. 
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Clean-up by solid phase extraction (SPE) 
 
Lytic compounds were extracted from the supernatant by reversed-phase SPE cartridge (LC-18,  
500 mg/6mL, Sigma-Aldrich, Deisenhofen, Germany). The cartridges were conditioned by 15 mL 
chloroform/methanol (3:1 (v/v)) and 15 mL 100% methanol and equilibrated with 15 mL water. First, 
in order to define a minimum volume of supernatant to be applied to SPE, a series of four volumes (10, 
50, 100, and 200 mL) of supernatant were applied to SPE cartridges and each eluted with 10 mL water, 
40% methanol, 100% methanol, and chloroform/methanol (3:1 (v/v)). Based on the preliminary test, 
100% methanol fractions were targeted, and dried by rotary-evaporation, re-dissolved in 5 mL   
K-medium and tested as a one-point bioassay of undiluted sample for lytic activity. In the next 
experiments, 200 mL supernatant in triplicate as well as 200 mL K-medium serving as negative control 
were applied to the cartridges, and eluted with 10 mL water twice and subsequently with 20 mL of 20, 
30, 40, 50, 60, 70, 80, 90, and 100% methanol, and finally with 10 mL chloroform/methanol   
[3:1 (v/v)]. Each eluate fraction except for first 10 mL sample load eluate (salt included) was dried by 
rotary evaporation and re-dissolved in 5 mL K-medium. Sub-samples of 3.9 mL each as well as the 
waste from the last 5 mL (195 to 200 mL) were tested as a one-point bioassay. Based on the results of 
the preliminary tests, the final SPE elution protocol is as follows: after sample (200 mL supernatant) 
loading the cartridge was washed with 10 mL water, 10 mL 20% methanol, 20 mL 50% methanol and 
10 mL 80% methanol.  
In order to quantify the lytic potency of two lytic fractions eluted with diverse eluents gained from 
SPE, 200 mL supernatant was applied to one C-18 cartridge, and the eluates were collected every  
20 mL. For the first 5 eluate collections, one-point (3.9 mL) bioassays were performed in duplicates, 
while a 4-point dilution curve (3.9, 2.0, 1.0, and 0.5 mL) was performed with last five eluate 
collections in duplicate. The loaded SPE column was eluted as the final protocol. 
The 10 mL water and the 10 mL 20% methanol fractions were combined and dried by rotary 
evaporation, and then were re-dissolved in 20 mL K-medium. To this H2O-20% methanol sample, a  
5-point dilution series was performed including a negative control (K-medium) to exclude possible 
salinity effect on Rhodomonas. The 10 mL 80% methanol fraction was separated into 2 aliquots. After 
dried by rotary evaporation, one aliquot was dissolved in 5 mL K-medium, while the other was 
dissolved in 5 mL leftover of 180–200 mL eluate collection. Bioassay with a 6-point dilution series for 
both 80% methanol sample and 80% methanol mixed sample as well as supernatant of the same batch 
in duplicate was performed. 
 
Effects of SPE fraction storage conditions on lytic activity 
 
Lytic effects of SPE fractions maintained under different storage conditions prior to applying the 
bioassay were investigated by applying 800 mL supernatant to 4 SPE cartridges (200 mL each) and 
eluted as described before. All 80% methanol fractions were pooled and split into 4 sub-samples   
(10 mL each). One sub-sample was stored in 80% methanol (1) in the fridge at 4 ºC. All other   
sub-samples were dried by rotary evaporation. One fraction was stored as dried sample (2), another 
resuspended in 5 mL water (3) and the last sample (4) re-suspended in 5 mL K-medium. After 2 days, 
aliquots (1) was rotary evaporated to dryness and then all aliquots were re-suspended in 10 mL   Mar. Drugs 2009, 7 
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K-medium. Immediately, a first bioassay was performed for each sample with a 6-point dilution curve 
in duplicate. All samples in culture medium were then stored in the fridge at 4 °C for an additional two 
days; thereafter new bioassays were performed with the same dilution series. 
 
Reversed phase HPLC  
 
HPLC was performed using an Agilent 1100 series (Agilent Technologies,Waldbronn, Germany) 
system. The LC-system consisted of a G1379A degasser, a G1311A quaternary pump, a G1229A 
autosampler, a G1330B autosampler thermostat, a G1316A column thermostat and a G1315B   
Diode-array detector (DAD). Chromatographic conditions were as follows: mobile phase A: water; 
mobile phase B: methanol. The flow rate was 0.2 mL/min with the following gradient: 0 until 15 min, 
5% to 100% B; isocratic 100% B until 27 min; 27 until 28 min, 100% to 5% B; isocratic 5% B until  
40 min (= total run time). The autosampler temperature was set at 25 °C and the injection volume was 
100 µL. One liter supernatant of both Alex2 and Alex5 cultures was cleaned up by C18 SPE   
(500 mg/6mL, Sigma-Aldrich, Deisenhofen, Germany). The 80% methanol fraction was collected, 
dried by rotary evaporation, and finally dissolved in 1 mL water. Before injection, the sample was 
spin-filtered (Eppendorf 5415R, 30 sec, 15,000 × g, room temperature) by filter unit insert (0.45 µm, 
Durapore, Millipore). The separation of analytes was performed on a 50 × 2.0 mm i.d., 3 µm, Hypersil 
BOS C8 reversed-phase column (Phenomenex, Aschaffenburg, Germany) equipped with a 
Phenomenex SecuriGuard pre-column. Based on preliminary result, eluate was collected very 1 min 
from 15 to 20 min, and lytic activity was detected in each fraction. Accordingly, the target range was 
detected over the wave length range 190–400 nm. 
 
Dry mass equivalent 
 
For the determination the dry mass equivalent of lytic activity, bioassays with dilution series were 
performed with supernatant, the lytic SPE fraction and the lytic HPLC fraction (details see above 
experiments). Based on the EC50 value, the corresponding volumes of the treatments were calculated. 
These respective treatment volumes were dried in a N2 stream and dry residues were weighed. 
 
5. Conclusions 
 
Analysis of physico/chemical characteristics of extracellular lytic compounds produced by A. 
tamarense indicate that these allelochemicals behave like amphipathic compounds. Although temporal 
stability is high, a large molecular- or aggregate-size and high adsorption caused massive loss of 
activity during various purification steps. Nevertheless, although the exact chemical nature of lytic 
compounds produced by Alexandrium spp. is still open, we now have the knowledge and tools to 
handle and prepare larger amounts of samples for further purification through high performance liquid 
chromatography (HPLC) needed for structural elucidation by mass spectrometric techniques (MALDI-
TOF or LC-MS/MS) and nuclear magnetic resonance (NMR) spectroscopy. 
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